Human Longevity

Valuation $50B

About Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Headquarters Human Longevity, San Diego
Founded 2013-01-01
Industry Biotechnology, Genetics, Health Care, Health Diagnostics
Last Funding Type Series B
Valuation 50
Total Funding $369.80 million dollars
IPO Status Private

Financial

Human Longevity may be growing as indicated by several news articles highlighting advancements and developments in the field. One article discusses innovative approaches to improving human longevity, suggesting progress in the industry. Another article from a reputable financial news source details the involvement of venture capital giants in the quest for longevity breakthroughs, which implies significant investment and interest in the sector. Additionally, a health news article reports on a company revolutionizing aging and healthspan, which could be indicative of a growing market and increased demand for longevity solutions.

Funding Rounds 5
Number of Lead Investors 3
Total Funding Amount  $369.80 million dollars
Number of Investors 15

Related Angels

Peter Diamandis
View profile
Bryan Johnson
View profile
Daniel Curran
View profile
Surender Punia
View profile
Lance White
View profile